Abstract
A 43-year-old man was treated with orchiectomy and radiotherapy for testicular seminoma. Four years later, he developed a typical Philadelphia chromosome positive chronic granulocytic leukemia. Since the patient was not eligible for bone marrow transplantation, he was treated with busulfan. Long term follow-up of patients who received radiotherapy for testicular seminoma is warranted in order to detect possible secondary tumors.
MeSH terms
-
Adult
-
Busulfan / therapeutic use
-
Combined Modality Therapy
-
Dysgerminoma / radiotherapy*
-
Dysgerminoma / surgery
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Male
-
Orchiectomy
-
Philadelphia Chromosome
-
Radiation Injuries*
-
Testicular Neoplasms / radiotherapy*
-
Testicular Neoplasms / surgery